美国 · SEC FORM 4
abrdn Healthcare Investors
HQH · NYSE · CIK 0000805267 · Closed-End Funds · Asset Management
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
2 同一窗口内观察到的 Form 4 交易行
1 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-07-16 · Mahai Chris LaVictoire.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -12.9%
- 3M
- -10.0%
- 6M
- +8.7%
- 12M
- —
波动率与流动性
- 波动率
- 22.2%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- —
- 细分行业
- Asset Management
市场数据
价格数据截至:2026-10-04 · 价格来源:OpenBB/yfinance · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 64,415
- 上期报告
- 78,570
- 日均成交量
- 129,103
- 回补天数
- ≤ 1.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Mahai Chris LaVictoire | 买入 (P) | Common Stock | 501 | USD 20.96 | USD 10,501 | SEC 申报 ↗ |
| 2024-07-16 | DiMartino Rose | 买入 (P) | Common Stock | 1,000 | USD 18.88 | USD 18,880 | SEC 申报 ↗ |
| 2024-04-09 | Goetz Kathleen | 买入 (P) | Common Stock | 525 | USD 16.42 | USD 8,620 | SEC 申报 ↗ |
| 2024-01-02 | Reit Todd | 买入 (P) | Common Stock | 1,000 | USD 16.93 | USD 16,930 | SEC 申报 ↗ |
| 2023-12-28 | Maher Bill | 买入 (P) | Common Stock | 1,000 | USD 16.58 | USD 16,580 | SEC 申报 ↗ |
| 2023-12-21 | Goodson Alan R | 买入 (P) | Common stock | 170 | USD 16.13 | USD 2,742 | SEC 申报 ↗ |
| 2023-09-25 | OMSTEAD DANIEL R | 买入 (P) | Shares of Beneficial Interest | 9,500 | USD 15.63 | USD 148,485 | SEC 申报 ↗ |
| 2023-09-20 | OMSTEAD DANIEL R | 买入 (P) | Shares of Beneficial Interest | 9,500 | USD 15.88 | USD 150,860 | SEC 申报 ↗ |
| 2022-03-23 | Goetz Kathleen | 买入 (P) | Shares of Beneficial Interest | 74 | USD 20.42 | USD 1,501 | SEC 申报 ↗ |
| 2022-01-26 | Goetz Kathleen | 买入 (P) | Shares of Beneficial Interest | 481 | USD 21.52 | USD 10,351 | SEC 申报 ↗ |
| 2020-10-26 | OMSTEAD DANIEL R | 买入 (P) | Shares of Beneficial Interest | 5,200 | USD 20.53 | USD 106,756 | SEC 申报 ↗ |
| 2020-10-21 | OMSTEAD DANIEL R | 买入 (P) | Shares of Beneficial Interest | 5,050 | USD 20.68 | USD 104,434 | SEC 申报 ↗ |
| 2020-09-23 | Bailey Jeffrey Allen | 买入 (P) | Shares of Beneficial Interest | 490 | USD 20.39 | USD 9,991 | SEC 申报 ↗ |
| 2020-05-21 | OMSTEAD DANIEL R | 买入 (P) | Shares of Beneficial Interest | 5,000 | USD 21.01 | USD 105,050 | SEC 申报 ↗ |
| 2020-03-17 | OMSTEAD DANIEL R | 买入 (P) | Shares of Beneficial Interest | 6,800 | USD 16.24 | USD 110,432 | SEC 申报 ↗ |
Form 4 申报证据
2 transaction lines in the latest 365-day window; 16 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Goodson Alan R | 卖出 (S) | Common Stock | 242 | USD 19.32 | USD 4,675 | SEC 申报 ↗ |
| 2026-07-16 | Mahai Chris LaVictoire | 买入 (P) | Common Stock | 501 | USD 20.96 | USD 10,501 | SEC 申报 ↗ |
展开近期 Form 4 证据 (2 grouped rows)
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | HQH |
| CIK | 0000805267 |
| 行业 | Closed-End Funds |
| 细分行业 | Asset Management Yahoo Finance |
| SEC SIC | Investment company (SEC forms N-2, N-2/A, N-30D) |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 16 transaction lines from 2020-03-17 to 2026-10-06 15 P purchase lines · 1 S sale lines · 0 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.